Stay updated on Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page.

Latest updates to the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%
- Check21 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; 'Back to Top' was removed. No other core content changes are indicated.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific types of renal cell carcinoma and related compounds, while removing several previous terms and classifications related to these topics.SummaryDifference4%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page.